Latest Drugs, Latest Approval in Antiadrenergic agents, centrally acting

What are Antiadrenergic agents, centrally acting?

Centrally acting antiadrenergic agents inhibit the stimulation of the central nervous system alpha-adrenergic receptors and decrease sympathetic stimulation to the blood vessels and the heart. They block the release and action of catecholamines (epinephrine, norepinephrine, dopamine), which are released in response to stress.

Centrally acting antiadrenergic agents make the heart beat slower and with less force, and relax the blood vessels. All these actions lead to a decrease blood pressure.

Centrally acting antiadrenergic agents are used to treat hypertension.

Name Updated
Methyldopa (Methyldopa [ meth-il-doe-pa ]) 17-Aug-2023
Clonidine (transdermal) (Clonidine (transdermal) [ kloe-ni-deen ]) 14-Aug-2023
Clonidine (injection) (Clonidine (injection) [ klon-i-deen ]) 14-Aug-2023
Lofexidine (Lofexidine [ loe-fex-i-deen ]) 11-Aug-2023
Aldomet (Methyldopa [ meth-il-doe-pa ]) 05-Aug-2023
Catapres (Clonidine (oral) [ kloe-ni-deen ]) 05-Aug-2023
Lucemyra (Lofexidine [ floe-fex-i-deen ]) 13-Jul-2023
Duraclon (injection) (Clonidine (injection) [ klon-i-deen ]) 13-Jul-2023
Catapres-tts (Clonidine (transdermal) [ kloe-ni-deen ]) 13-Jul-2023
Kapvay (Clonidine (oral) [ kloe-ni-deen ]) 11-Jul-2023
Intuniv (Guanfacine [ gwahn-fa-seen ]) 10-Jul-2023
Guanfacine (Guanfacine [ gwahn-fa-seen ]) 10-Jul-2023
Clonidine (Clonidine (oral) [ kloe-ni-deen ]) 10-Jul-2023